{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:28:20Z","timestamp":1793273300622,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8113","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,5,7]]},"DOI":"10.1038\/s41586-026-10192-5","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:02:29Z","timestamp":1770048149000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A broadly protective antibody targeting gammaherpesvirus gB"],"prefix":"10.1038","volume":"653","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-7420","authenticated-orcid":false,"given":"Cong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-3124","authenticated-orcid":false,"given":"Chu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Huang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Shu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5253-2592","authenticated-orcid":false,"given":"Sen-Fang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-3406","authenticated-orcid":false,"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-5591","authenticated-orcid":false,"given":"Mu-Sheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"10192_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","volume":"9","author":"E Cesarman","year":"2014","unstructured":"Cesarman, E. Gammaherpesviruses and lymphoproliferative disorders. Annu. Rev. Pathol. Mech. Dis. 9, 349\u2013372 (2014).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10192_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-024-2766-0","author":"L-Y Zhong","year":"2024","unstructured":"Zhong, L.-Y. et al. Research landmarks on the 60th anniversary of Epstein\u2013Barr virus. Sci. China Life Sci. https:\/\/doi.org\/10.1007\/s11427-024-2766-0 (2024).","journal-title":"Sci. China Life Sci."},{"key":"10192_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri, E. A., Cesarman, E. & Boshoff, C. Kaposi\u2019s sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10, 707\u2013719 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"10192_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","volume":"19","author":"SA Connolly","year":"2021","unstructured":"Connolly, S. A., Jardetzky, T. S. & Longnecker, R. The structural basis of herpesvirus entry. Nat. Rev. Microbiol. 19, 110\u2013121 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"10192_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-immunol-072710-081639","volume":"29","author":"E Barton","year":"2011","unstructured":"Barton, E., Mandal, P. & Speck, S. H. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29, 351\u2013397 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"10192_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0300985813520435","volume":"51","author":"D O\u2019Toole","year":"2014","unstructured":"O\u2019Toole, D. & Li, H. The pathology of malignant catarrhal fever, with an emphasis on ovine herpesvirus 2. Vet. Pathol. 51, 437\u2013452 (2014).","journal-title":"Vet. Pathol."},{"key":"10192_CR7","doi-asserted-by":"publisher","first-page":"115060","DOI":"10.1016\/j.jviromet.2024.115060","volume":"331","author":"GC Russell","year":"2025","unstructured":"Russell, G. C., Percival, A. & Grant, D. M. Indirect ELISA for analysis of malignant catarrhal fever virus-specific antibodies in a range of species. J. Virol. Methods 331, 115060 (2025).","journal-title":"J. Virol. Methods"},{"key":"10192_CR8","doi-asserted-by":"publisher","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-05-1076","volume":"65","author":"L Gillet","year":"2005","unstructured":"Gillet, L., Dewals, B., Farnir, F., de Leval, L. & Vanderplasschen, A. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Res. 65, 9463\u20139472 (2005).","journal-title":"Cancer Res."},{"key":"10192_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.vetmic.2005.11.008","volume":"113","author":"M Ackermann","year":"2006","unstructured":"Ackermann, M. Pathogenesis of gammaherpesvirus infections. Vet. Microbiol. 113, 211\u2013222 (2006).","journal-title":"Vet. Microbiol."},{"key":"10192_CR10","first-page":"283","volume":"51","author":"M Hricov\u00e1","year":"2007","unstructured":"Hricov\u00e1, M. & Mistr\u00edkov\u00e1, J. Murine gammaherpesvirus 68 serum antibodies in general human population. Acta Virol. 51, 283\u2013287 (2007).","journal-title":"Acta Virol."},{"key":"10192_CR11","first-page":"157","volume":"101","author":"J Mistrikova","year":"2000","unstructured":"Mistrikova, J. et al. New findings on the ecology and epidemiology of murine herpes virus isolated in Slovakia. Bratisl. Lek. Listy 101, 157\u2013162 (2000).","journal-title":"Bratisl. Lek. Listy"},{"key":"10192_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4149\/av_2013_02_105","volume":"57","author":"J \u010cipkov\u00e1-Jar\u010du\u0161kov\u00e1","year":"2013","unstructured":"\u010cipkov\u00e1-Jar\u010du\u0161kov\u00e1, J., Chalupkov\u00e1, A., Hrabovsk\u00e1, Z., W\u00e1gnerov\u00e1, M. & Mistr\u00edkov\u00e1, J. Biological and pathogenetic characterization of different isolates of murine gammaherpesvirus 68 (MHV-68) in the context of study of human oncogenic gammaherpesviruses. Acta Virol. 57, 105\u2013112 (2013).","journal-title":"Acta Virol."},{"key":"10192_CR13","first-page":"936","volume":"12","author":"C Sun","year":"2021","unstructured":"Sun, C., Chen, X. C., Kang, Y. F. & Zeng, M. S. The status and prospects of Epstein\u2013Barr virus prophylactic vaccine development. Front. Immunol. 12, 936 (2021).","journal-title":"Front. Immunol."},{"key":"10192_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.tim.2023.03.001","volume":"31","author":"L Zhong","year":"2023","unstructured":"Zhong, L. et al. Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents. Trends Microbiol. 31, 788\u2013804 (2023).","journal-title":"Trends Microbiol."},{"key":"10192_CR15","doi-asserted-by":"crossref","unstructured":"M\u00f6hl, B. S., Chen, J. & Longnecker, R. Gammaherpesvirus entry and fusion: a tale how two human pathogenic viruses enter their host cells. Adv. Virus Res. 104, 313\u2013343 (2019).","DOI":"10.1016\/bs.aivir.2019.05.006"},{"key":"10192_CR16","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/v14112372","volume":"14","author":"G-L Bu","year":"2022","unstructured":"Bu, G.-L., Xie, C., Kang, Y.-F., Zeng, M.-S. & Sun, C. How EBV infects: the tropism and underlying molecular mechanism for viral infection. Viruses 14, 2372 (2022).","journal-title":"Viruses"},{"key":"10192_CR17","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.3390\/v7122957","volume":"7","author":"RS Cooper","year":"2015","unstructured":"Cooper, R. S. & Heldwein, E. E. Herpesvirus gB: a finely tuned fusion machine. Viruses 7, 6552\u20136569 (2015).","journal-title":"Viruses"},{"key":"10192_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7240","volume":"6","author":"H-B Wang","year":"2015","unstructured":"Wang, H.-B. et al. Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat. Commun. 6, 6240 (2015).","journal-title":"Nat. Commun."},{"key":"10192_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1778","volume":"9","author":"Z-Z Lu","year":"2023","unstructured":"Lu, Z.-Z. et al. Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1\/2-mediated macropinocytosis. Sci. Adv. 9, eadg1778 (2023).","journal-title":"Sci. Adv."},{"key":"10192_CR20","doi-asserted-by":"crossref","unstructured":"Sathiyamoorthy, K., Chen, J., Longnecker, R. & Jardetzky, T. S. The COMPLEXity in herpesvirus entry. Curr. Opin. Virol. 24, 97\u2013104 (2017).","DOI":"10.1016\/j.coviro.2017.04.006"},{"key":"10192_CR21","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1073\/pnas.0810530106","volume":"106","author":"M Backovic","year":"2009","unstructured":"Backovic, M., Longnecker, R. & Jardetzky, T. S. Structure of a trimeric variant of the Epstein\u2013Barr virus glycoprotein B. Proc. Natl Acad. Sci. USA 106, 2880\u20132885 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10192_CR22","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","volume":"31","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV. Cell Host Microbe 31, 1882\u20131897.e10 (2023).","journal-title":"Cell Host Microbe"},{"key":"10192_CR23","doi-asserted-by":"publisher","first-page":"e2202371119","DOI":"10.1073\/pnas.2202371119","volume":"119","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion. Proc. Natl Acad. Sci. USA 119, e2202371119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10192_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","volume":"48","author":"J Snijder","year":"2018","unstructured":"Snijder, J. et al. An antibody targeting the fusion machinery neutralizes dual-tropic infection and defines a site of vulnerability on Epstein\u2013Barr virus. Immunity 48, 799\u2013811.e9 (2018).","journal-title":"Immunity"},{"key":"10192_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28793","volume":"95","author":"C Xie","year":"2023","unstructured":"Xie, C. et al. Anti-EBV antibodies: roles in diagnosis, pathogenesis, and antiviral therapy. J. Med. Virol. 95, e28793 (2023).","journal-title":"J. Med. Virol."},{"key":"10192_CR26","doi-asserted-by":"publisher","first-page":"e2502231","DOI":"10.1002\/advs.202502231","volume":"12","author":"X Fang","year":"2025","unstructured":"Fang, X. et al. Structure and antigenicity of Kaposi\u2019s sarcoma-associated herpesvirus glycoprotein B. Adv. Sci. 12, e2502231 (2025).","journal-title":"Adv. Sci."},{"key":"10192_CR27","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001673","volume":"102","author":"D Gatherer","year":"2021","unstructured":"Gatherer, D. et al. ICTV Virus Taxonomy Profile: herpesviridae 2021. J. Gen. Virol. 102, 001673 (2021).","journal-title":"J. Gen. Virol."},{"key":"10192_CR28","doi-asserted-by":"publisher","first-page":"e07012","DOI":"10.1002\/adma.202507012","volume":"38","author":"C Sun","year":"2026","unstructured":"Sun, C. et al. Chimeric glycoprotein nanoparticles elicit robust neutralizing antibodies against Epstein\u2013Barr virus. Adv. Mater. 38, e07012 (2026).","journal-title":"Adv. Mater."},{"key":"10192_CR29","doi-asserted-by":"publisher","first-page":"e02892-18","DOI":"10.1128\/mBio.02892-18","volume":"10","author":"J Chen","year":"2019","unstructured":"Chen, J., Zhang, X., Schaller, S., Jardetzky, T. S. & Longnecker, R. Ephrin receptor A4 is a new Kaposi\u2019s sarcoma-associated herpesvirus virus entry receptor. mBio 10, e02892-18 (2019).","journal-title":"mBio"},{"key":"10192_CR30","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/v14122709","volume":"14","author":"M B\u00f6ni","year":"2022","unstructured":"B\u00f6ni, M., Rieble, L. & M\u00fcnz, C. Co-infection of the Epstein\u2013Barr virus and the Kaposi sarcoma-associated herpesvirus. Viruses 14, 2709 (2022).","journal-title":"Viruses"},{"key":"10192_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12929-024-01045-2","volume":"31","author":"N Seyfizadeh","year":"2024","unstructured":"Seyfizadeh, N. et al. Development of a highly effective combination monoclonal antibody therapy against herpes simplex virus. J. Biomed. Sci. 31, 56 (2024).","journal-title":"J. Biomed. Sci."},{"key":"10192_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9176","volume":"6","author":"S Chandramouli","year":"2015","unstructured":"Chandramouli, S. et al. Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Nat. Commun. 6, 8176 (2015).","journal-title":"Nat. Commun."},{"key":"10192_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007452","volume":"14","author":"Z Si","year":"2018","unstructured":"Si, Z. et al. Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate. PLoS Pathog. 14, e1007452 (2018).","journal-title":"PLoS Pathog."},{"key":"10192_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev-cellbio-101512-122422","volume":"30","author":"B Podbilewicz","year":"2014","unstructured":"Podbilewicz, B. Virus and cell fusion mechanisms. Annu. Rev. Cell Dev. Biol. 30, 111\u2013139 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10192_CR35","doi-asserted-by":"publisher","first-page":"eabc1726","DOI":"10.1126\/sciadv.abc1726","volume":"6","author":"B Vollmer","year":"2020","unstructured":"Vollmer, B. et al. The prefusion structure of herpes simplex virus glycoprotein B. Sci. Adv. 6, eabc1726 (2020).","journal-title":"Sci. Adv."},{"key":"10192_CR36","doi-asserted-by":"publisher","first-page":"eabf3178","DOI":"10.1126\/sciadv.abf3178","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Sci. Adv. 7, eabf3178 (2021).","journal-title":"Sci. Adv."},{"key":"10192_CR37","doi-asserted-by":"publisher","unstructured":"Mccallum, M. & Veesler, D. Computational design of prefusion-stabilized herpesvirus gB trimers. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.10.23.619923 (2024).","DOI":"10.1101\/2024.10.23.619923"},{"key":"10192_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-virology-111821-093413","volume":"10","author":"JM White","year":"2023","unstructured":"White, J. M., Ward, A. E., Odongo, L. & Tamm, L. K. Viral membrane fusion: a dance between proteins and lipids. Annu. Rev. Virol. 10, 139\u2013161 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"10192_CR39","doi-asserted-by":"publisher","first-page":"e2404250121","DOI":"10.1073\/pnas.2404250121","volume":"121","author":"MR Sponholtz","year":"2024","unstructured":"Sponholtz, M. R. et al. Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation. Proc. Natl Acad. Sci. USA 121, e2404250121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10192_CR40","doi-asserted-by":"crossref","unstructured":"McCool, R. S. et al. Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen. Nat. Commun. 17, 1197 (2026).","DOI":"10.1038\/s41467-025-67969-x"},{"key":"10192_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01181-y","author":"C M\u00fcnz","year":"2025","unstructured":"M\u00fcnz, C. Epstein\u2013Barr virus pathogenesis and emerging control strategies. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-025-01181-y (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"10192_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","volume":"14","author":"PJ Farrell","year":"2019","unstructured":"Farrell, P. J. Epstein\u2013Barr virus and cancer. Annu. Rev. Pathol. Mech. Dis. 14, 29\u201353 (2019).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10192_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.pathol.1.110304.100133","volume":"1","author":"D Ganem","year":"2006","unstructured":"Ganem, D. KSHV infection and the pathogenesis of Kaposi\u2019s sarcoma. Annu. Rev. Pathol. Mech. Dis. 1, 273\u2013296 (2006).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10192_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-024-01774-8","volume":"9","author":"C Xie","year":"2024","unstructured":"Xie, C., Sun, C. & Zeng, M. S. Navigating Epstein\u2013Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal Transduct. Target. Ther. 9, 48 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10192_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49209-w","volume":"15","author":"N Caduff","year":"2024","unstructured":"Caduff, N. et al. KSHV infection of B cells primes protective T cell responses in humanized mice. Nat. Commun. 15, 4841 (2024).","journal-title":"Nat. Commun."},{"key":"10192_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.hlife.2024.07.002","volume":"2","author":"Z-Y Jiang","year":"2024","unstructured":"Jiang, Z.-Y. et al. Discovering broader antiviral strategies: role of interferon-induced transmembrane proteins in virus infection. hLife 2, 377\u2013379 (2024).","journal-title":"hLife"},{"key":"10192_CR47","doi-asserted-by":"publisher","first-page":"e0217824","DOI":"10.1128\/jvi.02178-24","volume":"4","author":"KP Karthigeyan","year":"2025","unstructured":"Karthigeyan, K. P. et al. A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice. J. Virol. 4, e0217824 (2025).","journal-title":"J. Virol."},{"key":"10192_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hlife.2023.12.004","volume":"2","author":"C Sun","year":"2024","unstructured":"Sun, C. et al. The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses. hLife 2, 141\u2013146 (2024).","journal-title":"hLife"},{"key":"10192_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41392-022-00910-6","volume":"7","author":"C Sun","year":"2022","unstructured":"Sun, C. et al. Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants. Signal Transduct. Target. Ther. 7, 42 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10192_CR50","doi-asserted-by":"publisher","first-page":"115168","DOI":"10.1016\/j.celrep.2024.115168","volume":"44","author":"C Sun","year":"2025","unstructured":"Sun, C. et al. Structural basis of Epstein\u2013Barr virus gp350 receptor recognition and neutralization. Cell Rep. 44, 115168 (2025).","journal-title":"Cell Rep."},{"key":"10192_CR51","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.xcrm.2020.100033","volume":"1","author":"S Singh","year":"2020","unstructured":"Singh, S. et al. Neutralizing antibodies protect against oral transmission of lymphocryptovirus. Cell Rep. Med. 1, 100033 (2020).","journal-title":"Cell Rep. Med."},{"key":"10192_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2017.06.009","volume":"22","author":"D McHugh","year":"2017","unstructured":"McHugh, D. et al. Persistent KSHV infection increases EBV-associated tumor formation in vivo via enhanced EBV lytic gene expression. Cell Host Microbe 22, 61\u201373.e7 (2017).","journal-title":"Cell Host Microbe"},{"key":"10192_CR53","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1128\/JVI.73.6.4651-4661.1999","volume":"73","author":"KE Weck","year":"1999","unstructured":"Weck, K. E., Kim, S. S., Virgin, H. W. & Speck, S. H. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73, 4651\u20134661 (1999).","journal-title":"J. Virol."},{"key":"10192_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101587","volume":"5","author":"KR Edwards","year":"2024","unstructured":"Edwards, K. R. et al. Vaccination with nanoparticles displaying gH\/gL from Epstein\u2013Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Cell Rep. Med. 5, 101587 (2024).","journal-title":"Cell Rep. Med."},{"key":"10192_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10192_CR56","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"10192_CR57","doi-asserted-by":"publisher","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature https:\/\/doi.org\/10.1038\/s41586-021-03819-2 (2021).","DOI":"10.1038\/s41586-021-03819-2"},{"key":"10192_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"10192_CR59","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10192_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10192_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."}],"updated-by":[{"DOI":"10.1038\/s41586-026-10745-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10192-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10192-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10192-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:03:12Z","timestamp":1781074992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10192-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":61,"journal-issue":{"issue":"8113","published-print":{"date-parts":[[2026,5,7]]}},"alternative-id":["10192"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10192-5","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-026-10745-8","URL":"https:\/\/doi.org\/10.1038\/s41586-026-10745-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that patent applications have been submitted referring to the gB monoclonal antibody Fab5 (China invention patent application number: 2024119048839, with M.-S.Z., C.S. and C.X. as inventors; PCT application number: PCT\/CN2025\/144285, with M.-S.Z., C.S. and C.X. as inventors). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}